摘要
采用气功及心痛定治疗45例肝阳上亢及阴虚阳亢型高血压患者,观察各组TXB2,6-K-PGF1α及TXB2/6-K-PGF1α值。结果显示,气功治疗组中,肝阳上亢型、阴虚阳亢型及心痛定组TXB2及TXB2/6-K-PGF1α值均明显下降,而6-K-PGF1α明显上升;TXB2及6-K-PGF1α含量变化组间差别无统计学意义。提示气功和心痛定对高血压患者的血浆TXB2及6-K-PGF1α均具有调节作用;而气功对肝阳上亢和阴虚阳亢两型作用近似。
orty--five patients of essential hypertension differentiated into two TCM types, i.e. Gan Yang Shang Kang Zheng(GYSK) and Yin Xu Yang Kang Zheng(YXYK) were randomly selected. Among them, the 31 patients received qigong therapy including 12 GYSK cases(group b) and 19 YXYK cases(group c) and 14 patients(group d) received nifedopine therapy. It was found that the plasma 6KPGF1αwas increased and TXB2 as well as TXB2/6KPGF1α ratio were decreased after the therapy (P<0.05) in group b, c and d. No statistical significant difference was found between group b and group c (P>0.05).The results suggest that qigong is regulatory on TXB2 and 6KPGF1α in patients with essential hypertension and is identical in the two different TCM Zheng types.
出处
《湖南医科大学学报》
CSCD
1997年第6期497-499,共3页
Bulletin of Hunan Medical University
基金
湖南省卫生厅基金
关键词
高血压
肝阳上亢
阴虚阳亢
气功疗法
Qigong* therapeutic use
hypertension
therapy
Gan Yang Shang Kang Zheng
Yin Xu Yang Kang Zheng
pathophysiology